Evidence map›Paper›PMID 42071201›Full record

ReviewJournal of hematology & oncology2026

Cytokines and cancer-associated fibroblasts.

Yidu Hu, Jiaqi Liang, Lewei Duan, Junkan Zhu, Guangyao Shan, Tao Cheng, Yingting Wu, Lijie Tan, Cheng Zhan

Abstract readReview
In one paragraph

Review in Journal of hematology & oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. SerumInternational journal of molecular sciences · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yidu Hu *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Jiaqi Liang *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Lewei Duan *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Junkan ZhuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Guangyao ShanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Tao ChengDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Yingting WuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China.
Lijie TanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China. tan.lijie@zs-hospital.sh.cn.
Cheng ZhanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, No. 180 Feng Lin Road Xuhui District, Shanghai, 200032, P.R. China. czhan10@fudan.edu.cn.

Funding

China Postdoctoral Science Foundation 2025M781926Fudan Undergraduate Research Opportunities Program Qingfeng Scholar Project QF2525National Natural Science Foundation of China 82473184National Natural Science Foundation of China 82503587Shanghai Sailing Program 24YF2704100
6 · The paper itself

Abstract

Cancer-associated fibroblast (CAF) is the dominant stromal component within the tumor microenvironment (TME), driving tumor malignancy through complex cell-to-cell communication, with cytokines serving as the fundamental communication medium. In this review, we systematically categorize cytokines into several major families-including interleukins, chemokines, growth factors, tumor necrosis factors, interferons, colony-stimulating factors, and complement system-to delineate their distinct roles in the reciprocal interactions around CAFs, tumor cells, and immune infiltrates. We explore how cytokines function as upstream signals that guide CAF activation and lineage commitment, as well as downstream effectors secreted by CAFs to promote tumor cell malignancy and reprogram the TME. Furthermore, we evaluate therapeutic strategies that target this network by reprogramming CAF functions through blockade of upstream activators or downstream mediators, and by harnessing CAFs for local cytokine delivery. Finally, we address key challenges impeding clinical translation-arising from the pleiotropy, functional redundancy, compensatory feedback loops and spatiotemporal heterogeneity that characterize cytokine signaling networks, as well as from the inherent limitations of current preclinical models-and we outline a theoretical framework for optimizing cytokine-targeted therapies in precision oncology.

Indexed as

Cancer-Associated FibroblastsCytokinesNeoplasmsAnimalsHumansSignal TransductionTumor MicroenvironmentCytokinesCancer-associated fibroblasts (CAFs)Cancer therapyCytokinesStromal reprogrammingTherapeutic targetingTumor microenvironment (TME)

Identifiers

PMID42071201
PMCPMC13307437

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.